You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 111 No. 2, February 1963 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (59)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Vascular Effect of the Thiazide Diuretics

JAMES CONWAY

Arch Intern Med. 1963;111(2):203-207.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

While it seems likely that the fall in blood pressure produced by the thiazide diuretics is a consequence of their sustained diuretic action, it has not been possible to demonstrate this with certainty, and the mode of action of diuretics in reducing blood pressure remains unexplained. Although there is a reduction in extracellular fluid and plasma volumes over the first few days after the drug is administered,1-3 these are later restored to their initial levels.4-7 Furthermore, it has been shown that cardiac output, though initially reduced, returns to normal levels after a period of weeks of continued therapy. Since the blood pressure continues to be reduced, the calculated total peripheral resistance is also reduced, and it has been inferred that the drug affects the blood vessels themselves.6 The purpose of this report is to acquire direct evidence by plethysmography for this action on the peripheral blood vessels . . . [Full Text PDF of this Article]


Author Affiliations

From Department of Internal Medicine, University of Michigan Medical Center.; Associate Professor of Internal Medicine and Physiology and Established Investigator of the American Heart Association (Dr. Conway); Research Assistant in the Department of Internal Medicine (Dr. Palmero).


Footnotes

Received for publication Aug. 15, 1962; accepted Sept. 27.

The spironolactone used in this study has been supplied by the G. D. Searle Company, Chicago, and the chlorothiazide by the Merck Sharp and Dohme Company, Pennsylvania.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1963 American Medical Association. All Rights Reserved.